Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Magnani

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Blood|January 11, 2022
Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myelomaNikolaos Trasanidis, Alexia Katsarou, Kanagaraju Ponnusamy, et al.
Cell Reports|September 29, 2015
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast CancerManikandan Periyasamy, Hetal Patel, Chun-Fui Lai, et al.
Nature Communications|December 8, 2019
High-resolution label-free 3D mapping of extracellular pH of single living cellsYanjun Zhang, Yasufumi Takahashi, Sung Pil Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast CancerHetal Patel, Rezvan Abduljabbar, Chun-Fui Lai, et al.
Cancer Discovery|March 25, 2024
Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer CellsDalia Rosano, Emre Sofyali, Heena Dhiman, et al.
Iscience|May 1, 2023
General anesthetic action profile on the human prefrontal cortex cells through comprehensive single-cell RNA-seq analysisEnqiang Chang, Yangyang Wang, Ruilou Zhu, et al.
Cancer Research|October 2, 2024
Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast CancerCarolina Gemma, Chun-Fui Lai, Anup K Singh, et al.
Oncotarget|July 29, 2015
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancerLuca Magnani, Darren K Patten, Van T M Nguyen, et al.
Clinical Epigenetics|July 10, 2026
Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancerJanina Müller, Emre Sofyali, Luisa Schwarzmüller, et al.
Clinical Epigenetics|April 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancerJanina Müller, Emre Sofyali, Luisa Schwarzmüller, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Blood|January 11, 2022
Systems medicine dissection of chr1q-amp reveals a novel PBX1-FOXM1 axis for targeted therapy in multiple myelomaNikolaos Trasanidis, Alexia Katsarou, Kanagaraju Ponnusamy, et al.
Cell Reports|September 29, 2015
APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast CancerManikandan Periyasamy, Hetal Patel, Chun-Fui Lai, et al.
Nature Communications|December 8, 2019
High-resolution label-free 3D mapping of extracellular pH of single living cellsYanjun Zhang, Yasufumi Takahashi, Sung Pil Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2016
Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor-Positive Breast CancerHetal Patel, Rezvan Abduljabbar, Chun-Fui Lai, et al.
Cancer Discovery|March 25, 2024
Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer CellsDalia Rosano, Emre Sofyali, Heena Dhiman, et al.
Iscience|May 1, 2023
General anesthetic action profile on the human prefrontal cortex cells through comprehensive single-cell RNA-seq analysisEnqiang Chang, Yangyang Wang, Ruilou Zhu, et al.
Cancer Research|October 2, 2024
Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast CancerCarolina Gemma, Chun-Fui Lai, Anup K Singh, et al.
Oncotarget|July 29, 2015
The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancerLuca Magnani, Darren K Patten, Van T M Nguyen, et al.
Clinical Epigenetics|July 10, 2026
Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancerJanina Müller, Emre Sofyali, Luisa Schwarzmüller, et al.
Clinical Epigenetics|April 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancerJanina Müller, Emre Sofyali, Luisa Schwarzmüller, et al.
Pageof 13